Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-08
DOI
10.1038/s41467-018-06951-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulation of the Immune Response by the Aryl Hydrocarbon Receptor
- (2018) Cristina Gutiérrez-Vázquez et al. IMMUNITY
- Towards Resolving the Pro- and Anti-Tumor Effects of the Aryl Hydrocarbon Receptor
- (2018) Supraja Narasimhan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- STAT3/p53 pathway activation disrupts IFN-β–induced dormancy in tumor-repopulating cells
- (2018) Yuying Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- The aryl hydrocarbon receptor in the crossroad of signalling networks with therapeutic value
- (2018) Ángel C. Roman et al. PHARMACOLOGY & THERAPEUTICS
- Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma
- (2018) Melanie Werner-Klein et al. Nature Communications
- Cancer drug addiction is relayed by an ERK2-dependent phenotype switch
- (2017) Xiangjun Kong et al. NATURE
- Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
- (2017) Sydney M. Shaffer et al. NATURE
- A non-coding function of TYRP1 mRNA promotes melanoma growth
- (2017) David Gilot et al. NATURE CELL BIOLOGY
- Comparative analysis of TCDD-induced AhR-mediated gene expression in human, mouse and rat primary B cells
- (2017) Natalia Kovalova et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Recurrent Tumor Cell–Intrinsic and –Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early Adaptation
- (2017) Chunying Song et al. Cancer Discovery
- The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth
- (2017) Kimberley Hanson et al. Oncotarget
- Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy
- (2016) Michael P. Smith et al. CANCER CELL
- Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF–CRAF Heterodimerization
- (2016) Lise Boussemart et al. CANCER RESEARCH
- MAPK Pathway Inhibitors Sensitize BRAF-Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB
- (2016) A. A. N. Rose et al. CLINICAL CANCER RESEARCH
- Role for the Aryl Hydrocarbon Receptor and Diverse Ligands in Oral Squamous Cell Carcinoma Migration and Tumorigenesis
- (2016) E. A. Stanford et al. MOLECULAR CANCER RESEARCH
- Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
- (2016) I. Tirosh et al. SCIENCE
- BRAF V600E Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived Xenografts
- (2016) Kristel Kemper et al. Cell Reports
- Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance
- (2015) Willy Hugo et al. CELL
- Unrevealing the role of P-protein on melanosome biology and structure, using siRNA-mediated down regulation of OCA2
- (2015) Sangjoo Park et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis
- (2015) María Contador-Troca et al. Molecular Cancer
- RAF inhibitors that evade paradoxical MAPK pathway activation
- (2015) Chao Zhang et al. NATURE
- Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
- (2015) Silvana Konermann et al. NATURE
- Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
- (2015) Annelien Verfaillie et al. Nature Communications
- Potential Therapeutic Strategies to Overcome Acquired Resistance to BRAF or MEK Inhibitors in BRAF Mutant Cancers
- (2015) Ryan B. Corcoran et al. Oncotarget
- Ligand Promiscuity of Aryl Hydrocarbon Receptor Agonists and Antagonists Revealed by Site-Directed Mutagenesis
- (2014) A. A. Soshilov et al. MOLECULAR AND CELLULAR BIOLOGY
- p53 Requires the Stress Sensor USF1 to Direct Appropriate Cell Fate Decision
- (2014) Amine Bouafia et al. PLoS Genetics
- Aryl Hydrocarbon Receptor Activation by Dioxin Targets Phosphoenolpyruvate Carboxykinase (PEPCK) for ADP-ribosylation via 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-inducible Poly(ADP-ribose) Polymerase (TiPARP)
- (2013) Silvia Diani-Moore et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A melanocyte lineage program confers resistance to MAP kinase pathway inhibition
- (2013) Cory M. Johannessen et al. NATURE
- Role of the Aryl Hydrocarbon Receptor in Carcinogenesis and Potential as a Drug Target
- (2013) Stephen Safe et al. TOXICOLOGICAL SCIENCES
- A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ERα protein
- (2012) Chi Tze Tiong et al. CARCINOGENESIS
- Malignant Transformation of Mammary Epithelial Cells by Ectopic Overexpression of the Aryl Hydrocarbon Receptor
- (2012) J. Brooks et al. CURRENT CANCER DRUG TARGETS
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
- (2011) Nikhil Wagle et al. JOURNAL OF CLINICAL ONCOLOGY
- An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
- (2011) Christiane A. Opitz et al. NATURE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- RNAi-Based Screening Identifies Kinases Interfering with Dioxin-Mediated Up-Regulation of CYP1A1 Activity
- (2011) David Gilot et al. PLoS One
- The aryl hydrocarbon receptor: fine-tuning the immune-response
- (2010) Marc Veldhoen et al. CURRENT OPINION IN IMMUNOLOGY
- The Aryl Hydrocarbon Receptor Mediates UVB Radiation–Induced Skin Tanning
- (2010) Bettina Jux et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Cancer stem cells versus phenotype-switching in melanoma
- (2010) Keith S. Hoek et al. Pigment Cell & Melanoma Research
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Activation of the Aryl Hydrocarbon Receptor by the Calcium/Calmodulin-Dependent Protein Kinase Kinase Inhibitor 7-Oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic Acid (STO-609)
- (2008) P. Monteiro et al. DRUG METABOLISM AND DISPOSITION
- Cyclical DNA methylation of a transcriptionally active promoter
- (2008) Raphaël Métivier et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now